Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

The impact of disease severity and treatment of psoriasis on specific quality of life measure in patients with psoriasis (CROSBI ID 546148)

Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | domaća recenzija

Guina, Tina ; Brajac, Ines ; Kaštelan, Marija ; Manestar-Blažić, Teo The impact of disease severity and treatment of psoriasis on specific quality of life measure in patients with psoriasis // 2nd Croatian Congress of Psychodermatology with International Participation, Abstract Book. 2008. str. 26-27

Podaci o odgovornosti

Guina, Tina ; Brajac, Ines ; Kaštelan, Marija ; Manestar-Blažić, Teo

engleski

The impact of disease severity and treatment of psoriasis on specific quality of life measure in patients with psoriasis

Background: According to recent studies, psoriasis has a profound impact on patient’ s quality of life. However, the relationship between specific disease severity and quality of life measures and the impact of different therapies and sociodemographic variables on quality of life is not clarified sufficiently. Aim: To examine the impact of disease severity (PASI), sociodemografic variables and different treatment modalities on specific quality of life measure (Psoriasis Index of Quality of Life) in patients with psoriasis. Patients and methods: Sixty psoriasis patients attending a psoriasis outpatient setting underwent a clinical assessment using the Psoriasis Area and Severity Index (PASI) and completed a questionnaire that included questions on sociodemographic and medical data and specific quality of life instrument (Psoriasis Index of Quality of Life). Results: PASI failed to correlate significantly with the Psoriasis Index of Quality of Life. However, differences in method of treatment for psoriasis, as well as sociodemographic variables, significantly affect scores on the psoriasis-specific quality of life measures. Conclusion: The aim of the treatment, beside the minimizing severity and the extent of the disease, should also be able to reduce the impact on psoriasis on quality of life. Sociodemografic factors should also be discussed prior to treatment decision.

quality of life; psoriasis

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

26-27.

2008.

objavljeno

Podaci o matičnoj publikaciji

2nd Croatian Congress of Psychodermatology with International Participation, Abstract Book

Podaci o skupu

2nd Croatian Congress of Psychodermatology with International Participation

predavanje

25.09.2008-28.09.2008

Zagreb, Hrvatska

Povezanost rada

Kliničke medicinske znanosti